ATC Group: A01AD02 Benzydamine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A01AD02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A01 Stomatological preparations
3 A01A Stomatological preparations
4 A01AD Other agents for local oral treatment
5 A01AD02 Benzydamine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 9 mg

Active ingredients in A01AD02

Active Ingredient Description
Benzydamine

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.

Related product monographs

Title Information Source Document Type  
DIFFLAM Lozenge Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PHARIXIA Mouthwash Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.